Posted on AstraZeneca Battles Supply Chain Issues, Denies Claims Its Covid-19 Vaccine Is Largely Ineffective In Seniors
Posted on Billionaire Eric Lefkofsky’s Tempus Raises $200 Million To Bring Personalized Medicine To New Diseases
Posted on Dosing Error By Researchers In The AstraZeneca-Oxford University Vaccine Trial Boosted Its Success Rate To 90%